Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk

International Journal of Gynecological Cancer

Volumn 19, Issue 1, 2009, Pages 65-72

  Chêne, Gautier ^a   Penault Llorca, Frederique ^a   Bouëdec, Guillaume Le ^a   Mishellany, Florence ^a   Dauplat, Marie Melanie ^b   Jaffeux, Patricia ^c   Aublet Cuvelier, Bruno ^c   Pouly, Jean Luc ^d   Déchelotte, Pierre ^a   Dauplat, Jacques ^a  

^a CENTRE JEAN PERRIN   (France)

^b HÔTEL DIEU   (France)

^c CHU   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

BRCA mutation; Neoplasm; Ovarian dysplasia; Ovary; Prophylactic oophorectomy

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; CYTOLOGY; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARIAN EPITHELIAL DYSPLASIA; OVARIECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; GENETICS; MIDDLE AGED; OVARY DISEASE; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OVARIAN DISEASES; OVARIECTOMY; RETROSPECTIVE STUDIES;

EID: 65649115078     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181990127     Document Type: Article

References (35)

1. Brewer MA, Johnson K, Follen M, et al. Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res. 2003;9(1):20-30.
2. Bewtra C, Watson P, Conway TA, et al. Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol. 1992;11:180-187.
3. Ford D, Easton DF, Bishop T, et al. Risk of cancer in BRCA 1 mutation carriers. Lancet. 1994;343:692-695.
4. Lynch HT, Bewtra C, Lynch JF. Familial ovarian carcinoma. Am J Med. 1986;81:1073-1076.
5. Piver MS, Wong C. Prophylactic oophorectomy: a century-long dilemma. Hum Reprod. 1997;12:(2): 205-206.
6. Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58-64.
7. Schloosshauer PW, Cohen CJ, Penault-Lllorca F, et al. Prophylactic oophorectomy. Cancer. 2003;98:2599-2606.
8. Fathalla M. Incessant ovulation: a factor in ovarian neoplasia? Lancet. 1971;2:163-165.
9. Hamilton TC, Godwin AK, Ozols RF. Ovarian carcinogenesis. In Ovarian Cancer. Paris: Arnette Blackwell, 1996: 21-38.
10. Bershuck A, Kohler MF, Boente MP, et al. Growth regulation and transformation of ovarian epithelium. Cancer. 1993;71:545-551.
11. Wong AST, Auersperg N. Ovarian surface epithelium: family history and early events in ovarian cancer. Reprod Biol Endocrinol. 2003;70:1-8.
12. Gusberg SB, Deligdish L. Ovarian dysplasia, a study of identical twins. Cancer. 1984;54:1-4.
13. Deligdisch L, Gil J, Kerner H, et al. Ovarian dysplasia in prophylactic oophorectomy specimens. Cancer. 1999;86:1544-1550.
14. Deligdisch L, Einstein AJ, Guera D, et al. Ovarian dysplasia in epithelial inclusion cysts. Cancer 1995;76:1027-1034.
15. Deligdisch L. Ovarian dysplasia: a review. Int J Gynecol Cancer. 1997;7:89-94.
16. Salazar H, Godwin AK, Daly MB, et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst. 1996;88: 1810-1820.
17. Werness BA, Afify AM, Bielat KL, et al. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol. 1999;30:151-157.
18. Stratton JF, Buckey CH, Lowe D, et al. Comparison of prophylactic oophorectomy specimens from carriers and non carriers of a BRCA1 or BRCA2 gene mutation. J Natl Cancer Inst. 1999;91(7):626-628.
19. Barakat RR, Federici MG, Saigo PE, et al. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimen from BRCA1 heterozygotes. Cancer. 2000;89:383-390.
20. Heller DS, Hameed M, Baergen R. Lack of proliferative activity of surface epithelial inclusion cysts of the ovary. Int J Gynecol Cancer. 2003;13:303-307.
21. Plaxe S, Deligdish L, Dottino P, et al. Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecol Oncol. 1990;38:367-372.
22. Nieto JJ, Crow J, Sundaresan M, et al. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Gynecol Oncol. 2001;82:344-349.
23. Brewer MA, Ranger-Moore J, Baruche A, et al. Exploratory study of ovarian intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2005;14(2):299-305.
24. Tok EC, Ertung D, Tataroglu C, et al. Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women. Int J Gynecol Cancer. 2006;16:501-506.
25. Zheng J,Wan M, Zweizig S, et al. Histologically or low grade malignant tumors adjacent to high grade ovarian carcinomas contain molecular characteristics of high grade carcinomas. Cancer Res. 1993;53: 4138-4142.
26. Mittal KR, Jacquotte AZ, Cooper JL, et al. Controlateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol. 1993;12:59-63.
27. Tressera F, Grases PJ, Labastida R, et al. Histological features of the controlateral ovary in patients with unilateral ovarian cancer: a case control study. Gynecol Oncol. 1998;71:437-441.
28. Deligdisch L, Gil J. Characterization of ovarian dysplasia by interactive morphometry. Cancer. 1989;63:748-755.
29. Deligdisch L, Miranda C, Barba J, et al. Ovarian dysplasia: nuclear texture analysis. Cancer. 1993;72:3253-3257.
30. Deligdisch L, Gil J, Kerner H, et al. Ovarian dysplasia in prophylactic oophorectomy specimens. Cytogenetic and morphometric correlations. Cancer. 1999;86(8):1544-1550.
31. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30(2): 230-236.
32. Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007;25(25): 3985-3990
33. Leunen K, Legius E, Moerman P, et al. Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia. Int J Gynecol Cancer. 2006;16:183-188.
34. Piek JM, van Diest PJ, Zweemer RP. Dysplastic changes in prophylactic removed fallopian tubes of women predisposed to ovarian cancer. J Pathol. 2001;195:451-456.
35. Crum CP, Drapkin R, Kindelberger D, et al. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5(1):35-44.